about
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability.Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncology.Attitudes toward infection prophylaxis in pediatric oncology: a qualitative approachCost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy.Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaeniaChemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals.An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications.Health economic evaluation: a primer for the practicing rheumatologist.Economic evaluations of anticoagulants for the prophylaxis of venous thromboembolism following major trauma.Decision making in pediatric oncology: evaluation and incorporation of patient and parent preferences.Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.Public engagement in priority-setting: results from a pan-Canadian survey of decision-makers in cancer control.The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia.Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis.Bayesian and classical estimation of mixed logit: An application to genetic testing.Cost-effectiveness of therapeutic hypothermia to treat neonatal encephalopathy.Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.Task complexity and response certainty in discrete choice experiments: An application to drug treatments for juvenile idiopathic arthritisEconomic evaluation of hypothermic neural rescuePerspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancerResponse to ‘Marginal Costs of Hospital-Acquired Conditions: Information for Priority-Setting for Patient Safety Programmes and Research'’, Jackson et al., Journal of Health Services Research & Policy 2011;16:141–6Study of progesterone for the prevention of preterm birth in twins (STOPPIT): Findings from a trial-based cost-effectiveness analysis—ErratumCost–effectiveness of tumor necrosis factor-α antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisEconomic Analyses alongside Cancer Clinical TrialsAllocating healthcare resources to genomic testing in Canada: latest evidence and current challengesBalancing uncertainty with patient autonomy in precision medicineDemand for Precision Medicine: A Discrete-Choice Experiment and External Validation StudyGenetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication
P50
Q30557139-1F6A4443-6F85-4736-B9B3-624C442C2C57Q33847214-DE9F3C08-CBFC-4212-A356-1DEA90D64503Q34452116-A9BFDAB1-8916-477C-A72D-EBCA9BBE974FQ34462307-561B521B-3A9C-4AD1-8C80-C816276BE088Q34667522-F562F7BA-434B-4B89-A722-87A23D9475B3Q35287551-5206E87E-987B-4F49-8787-8B66AD535A59Q35576989-BD41823B-D209-410E-96A5-DF8B42B5BAE0Q36055449-7F97A7EB-D77A-4014-B793-0598B6A4870EQ36178723-375F6E0A-38EF-4C6D-9B54-34308186EC91Q36549813-5A3E0725-C679-4BB8-B369-200F13604787Q37763146-BDEAEA24-3C40-45D0-ADFC-B96A1C608137Q38071054-64225067-0AC2-4060-A8C4-D281141D5189Q38075667-E62782CB-B2BC-4199-80BD-1D4799BEC08BQ38274048-75F60C3D-0483-4E04-A405-75F14F681509Q38678657-D42D9C55-7D8F-49AE-894A-7C1BCD1EA42EQ39739727-D3C08A2A-BF91-4A09-AAB7-31D21FA82626Q40293094-98C8435F-8B37-41DE-8ABD-9679073B65DBQ43099575-9B22894F-9145-4C37-8E24-137327A747B7Q45256708-6D239443-2B89-418E-B1D4-2328EFF97C1EQ48159960-7FEC0BC0-0E46-4B92-8D3B-0EA7995EC4F7Q50951381-C3DA6653-3C33-47B2-9E8E-2D0809B0C017Q57658686-024F1FC5-4370-4882-8DC9-A558FFFCC177Q57658690-632262E7-6435-4D64-A27F-5FF7EE6DDA0AQ57658700-CE0C57CC-686D-48F5-A001-01D50133BB66Q57658703-8FE84FB9-790F-466C-8FCD-CE9E610E6811Q57658707-EBC7D5F4-11C5-4D79-90D0-0F77EF84563CQ57658712-8791741A-4FE7-4167-96C1-A384548F7715Q57745833-6DEECA42-2836-44CE-890A-B749713AD3B9Q91625514-EBE13129-8D6D-45F8-B13F-047063CB427AQ92372359-0451E0FC-7644-4487-A363-94DC95F60142Q93138837-6C9CE638-02E1-4540-BC7D-930DD69CB36AQ93251985-99BCDCD3-D1EA-4FD9-BDAE-DD9415D7EFF1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dean Regier
@ast
Dean Regier
@en
Dean Regier
@es
Dean Regier
@nl
Dean Regier
@sl
type
label
Dean Regier
@ast
Dean Regier
@en
Dean Regier
@es
Dean Regier
@nl
Dean Regier
@sl
prefLabel
Dean Regier
@ast
Dean Regier
@en
Dean Regier
@es
Dean Regier
@nl
Dean Regier
@sl
P106
P108
P1153
8642467500
P2038
Dean_Regier2
P21
P31
P496
0000-0001-8876-0511
P569
2000-01-01T00:00:00Z